InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,724.80
(
0.01%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
82.95
(
-0.32%
)
Bitcoin
61,808.52
(
-1.74%
)
Post# of 821321
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Let's Roll

Send PM Follow Ignore
Followers 883
Posts 304355
Boards Moderated 5
Alias Born 06/09/2006

Let's Roll

Re: None

Friday, 02/17/2017 9:53:54 AM

Friday, February 17, 2017 9:53:54 AM

Post# of 821321
$IMLFF InMed Pharmaceuticals Inc. is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual (or combination of) cannabinoids against disease targets, a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all 90+ cannabinoids at pharmaceutical-grade (>99.5% purity), and drug development program.

The full research report has a comprehensive overview of InMed's financials, pipeline and potential obstacles READ MORE

(Copy and paste to your browser may be required to view the full report- http://bit.ly/2kA730w-IMLFF-Analyst)

https://finance.yahoo.com/news/inmeds-cannabis-pipeline-financials-prospects-130000009.html

$VBIO $GWPH $AXIM

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up